Ipamorelin vs Sermorelin vs Tesamorelin: Growth Hormone Comparison

Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

A comparison of the growth hormone-releasing peptides Ipamorelin, Sermorelin, and Tesamorelin, covering their benefits and use cases.

# Ipamorelin vs Sermorelin vs Tesamorelin: Growth Hormone Comparison

Growth hormone (GH) is a vital hormone that plays a crucial role in growth, metabolism, and overall health. As we age, our natural production of GH declines, which can lead to a variety of age-related symptoms. Growth hormone-releasing peptides (GHRPs) are a class of peptides that can stimulate the body to produce more of its own GH. Among the most popular GHRPs are Ipamorelin, Sermorelin, and Tesamorelin. This article will compare these three peptides to help you understand their similarities and differences.

Ipamorelin: The Selective GH Stimulator

Ipamorelin is a newer generation GHRP that is known for its high selectivity. It stimulates the pituitary gland to release GH without significantly affecting other hormones like cortisol or prolactin. This makes it a popular choice for those who are looking for a clean and targeted approach to GH optimization.

How it Works

Ipamorelin mimics the action of ghrelin, a hormone that stimulates the release of GH from the pituitary gland. It is a pentapeptide, meaning it is composed of five amino acids.

Best For

Anti-aging

Improved sleep

Increased lean muscle mass

Fat loss

Sermorelin: The Original GHRP

Sermorelin is one of the first GHRPs to be developed. It is a 29-amino acid peptide that is a fragment of growth hormone-releasing hormone (GHRH). Like other GHRPs, it stimulates the pituitary gland to produce and release more GH.

How it Works

Sermorelin works by binding to the GHRH receptor in the pituitary gland, which triggers the synthesis and release of GH.

Best For

Anti-aging

Improved energy levels

Increased bone density

Overall wellness

Tesamorelin: The FDA-Approved Fat Burner

Tesamorelin is a synthetic form of GHRH that is FDA-approved for the treatment of lipodystrophy (abnormal fat distribution) in HIV patients. It is a potent stimulator of GH and has been shown to be particularly effective at reducing visceral fat, which is the dangerous fat that surrounds the organs.

How it Works

Tesamorelin works in the same way as Sermorelin, by binding to the GHRH receptor in the pituitary gland. However, it is a more stable and longer-acting molecule.

Best For

Reducing visceral fat

Improving body composition

Treating lipodystrophy

Comparison Table

| Peptide | Type | Primary Benefit | FDA Approved |

| --- | --- | --- | --- |

| Ipamorelin | GHRP | Selective GH release | No |

| Sermorelin | GHRH | Overall wellness | No |

| Tesamorelin | GHRH | Visceral fat reduction | Yes |

Which Peptide is Right for You?

The best peptide for you will depend on your individual goals. If you are looking for a selective and targeted approach to GH optimization with minimal side effects, Ipamorelin may be the best choice. If you are looking for a more general anti-aging and wellness peptide, Sermorelin is a good option. And if your primary goal is to reduce visceral fat, Tesamorelin is the most effective and is FDA-approved for this purpose.

Key Takeaways

Ipamorelin, Sermorelin, and Tesamorelin are all effective at stimulating the release of growth hormone.

Ipamorelin is the most selective, while Tesamorelin is the most potent at reducing visceral fat.

The best peptide for you will depend on your individual goals and needs.

> Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.

References

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699647/

[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/200512s000lbl.pdf

[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922769/

[4] https://honestpeptide.com/research/sermorelin-vs-ipamorelin-vs-tesamorelin

---

Related Articles

  • 10 Peptide Therapy Misconceptions: Setting the Record Straight
  • 2023 Year in Review: The Year the FDA Banned 19 Peptides
  • 2024 Year in Review: FDA Peptide Actions and Legal Battles
  • 2025 Year in Review: FDA Peptide Regulation Highlights